Instead, TGF-β downregulation was accompanied by weak activation of p38 and a few antiapoptotic molecules, reflecting a low sensitivity of cancer cells with higher levels of TGF-β to TGF-β treatment and again verifying a role of TGF-β as a regulator of cancer cell progression58,71. The gene discussed is MAPK14; the disease is cancer.